[go: up one dir, main page]

FR2899477B1 - Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t - Google Patents

Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t

Info

Publication number
FR2899477B1
FR2899477B1 FR0651271A FR0651271A FR2899477B1 FR 2899477 B1 FR2899477 B1 FR 2899477B1 FR 0651271 A FR0651271 A FR 0651271A FR 0651271 A FR0651271 A FR 0651271A FR 2899477 B1 FR2899477 B1 FR 2899477B1
Authority
FR
France
Prior art keywords
glycosides
lymphocytes
activator
lactose
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0651271A
Other languages
English (en)
Other versions
FR2899477A1 (fr
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0651271A priority Critical patent/FR2899477B1/fr
Priority to PCT/EP2007/053386 priority patent/WO2007116023A1/fr
Priority to EP07727854A priority patent/EP2012743A1/fr
Priority to US12/296,311 priority patent/US20100160251A1/en
Priority to CNA2007800212376A priority patent/CN101466351A/zh
Publication of FR2899477A1 publication Critical patent/FR2899477A1/fr
Application granted granted Critical
Publication of FR2899477B1 publication Critical patent/FR2899477B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0651271A 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t Expired - Fee Related FR2899477B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0651271A FR2899477B1 (fr) 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t
PCT/EP2007/053386 WO2007116023A1 (fr) 2006-04-07 2007-04-05 Utilisation de c-glycosides dérivé de lactose comme agent protecteur et/ou activateur des lymphocytes gamma delta t
EP07727854A EP2012743A1 (fr) 2006-04-07 2007-04-05 Composes d'imidazole
US12/296,311 US20100160251A1 (en) 2006-04-07 2007-04-05 Imidazo compounds
CNA2007800212376A CN101466351A (zh) 2006-04-07 2007-04-05 乳糖的衍生C-糖苷作为γδT淋巴细胞保护剂和/或激活剂的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651271A FR2899477B1 (fr) 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t

Publications (2)

Publication Number Publication Date
FR2899477A1 FR2899477A1 (fr) 2007-10-12
FR2899477B1 true FR2899477B1 (fr) 2008-05-30

Family

ID=37311842

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651271A Expired - Fee Related FR2899477B1 (fr) 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t

Country Status (5)

Country Link
US (1) US20100160251A1 (fr)
EP (1) EP2012743A1 (fr)
CN (1) CN101466351A (fr)
FR (1) FR2899477B1 (fr)
WO (1) WO2007116023A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010510B1 (fr) * 2006-04-07 2017-06-07 L'Oréal Utilisation d'un composé c-glycoside dérivé du lactose en tant qu'agent pour activer et réguler l'immunité cutanée
CN119242592B (zh) * 2024-10-16 2025-12-05 江南大学 一种分泌甘宝素单克隆抗体的杂交瘤细胞株及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818646B1 (fr) * 2000-12-22 2006-06-23 Oreal Nouveaux derives c-glycoside et utilisation
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
FR2869317B1 (fr) * 2004-04-23 2008-08-29 Oreal Nouveaux derives c-glycosides et utilisations cosmetiques
FR2882516B1 (fr) * 2005-02-25 2007-05-25 Oreal Utilisation capillaire des derives c-glycosides

Also Published As

Publication number Publication date
CN101466351A (zh) 2009-06-24
WO2007116023A1 (fr) 2007-10-18
EP2012743A1 (fr) 2009-01-14
US20100160251A1 (en) 2010-06-24
FR2899477A1 (fr) 2007-10-12

Similar Documents

Publication Publication Date Title
EP2115570A4 (fr) Agents de protection et modes de privilège
EP2143443A4 (fr) Utilisation combinée de composé inhibiteur de dipeptidylpeptidase iv, et d'adoucisseur
EP1812049A4 (fr) Inhibiteurs de kallikreine et leurs utilisations
EP2232003A4 (fr) Fluide de broyage et procédés d'utilisation de ce fluide
EP1943875A4 (fr) Casque et procédé d'utilisation afférent
IL192906A0 (en) Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
EP2187742A4 (fr) Dérivés de benzylbenzène et procédés d'utilisation
ATE544758T1 (de) Carboxamidverbindungen und ihre verwendung als calpain-hemmer
EP1732904A4 (fr) Utilisation de diaryltriazoles comme inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase-1
EP1992360A4 (fr) Utilisation en association d'un inhibiteur de signal tgf-beta et d'un agent antitumeur
EP2235034A4 (fr) Agents immunomodulatoires et procédés d'utilisation
PL1963451T3 (pl) Przekładka rozdzielająca do klejów przylepcowych i sposób jej użycia
EP2066294A4 (fr) Compositions immunomodulatrices et leurs procédés d'utilisation
IL189217A0 (en) Bridged n-bicylic sulfonamido inhibitors of gamma secretase
DE602007000304D1 (de) Schützende und regenerierende Zusammensetzung
BRPI0923761A2 (pt) copolímeros de bloco acrílico para aerossóis e adesivos de aerosol
SE0601155L (sv) Gas- och vätsketät skyddsdräkt
SE0702581L (sv) Idrottshandske med handledsskydd
EP2037944A4 (fr) Étalon de tacrolimus et ses procédés d'utilisation
EP2126056A4 (fr) Inhibiteurs de la famille des paramyxovirus et procédés d'utilisation de ceux-ci
FR2899467B1 (fr) Utilisation de derive c-glycosides comme agent protecteur et/ou activateur des lymphocytes gamma delta t
FR2899477B1 (fr) Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t
GB2438067B (en) Cooling and protecting mammalian bodies
FR2899469B1 (fr) Utilisation de derive de d- et l-fucose comme agent protecteur et/ou activateur des lymphocytes gamma delta t
FR2899468B1 (fr) Utilisation de c-glycosides derives de galactose comme agent protecteur et/ou activateur des lumphocytes gamma delta t

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121228